A Trial of ALN-6457 in Adult Participants With Symptomatic Prion Disease (PrD)
A Trial of ALN-6457 in Adult Participants With Symptomatic Prion Disease (PrD)
Not yet recruiting · NCT07832370 · Registry updated 2026-09-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Trial of ALN-6457 in Adult Participants With Symptomatic Prion Disease (PrD) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Creutzfeldt Jacob disease, Dyssomnias, Gerstmann-Straussler-Scheinker syndrome, Infections, Nutritional and Metabolic Diseases, Sleep Disorders, Intrinsic, brain disorder, central nervous system disorder, central nervous system infectious disorder, cognitive disorder, dementia, fatal familial insomnia, hereditary disease, inherited neurodegenerative disorder, insomnia, metabolic disease, nervous system disorder, neurodegenerative disease, prion disease, proteostasis deficiencies, psychiatric disorder, sleep-wake disorder | Not yet recruiting | Phase 1 / Phase 2 | 2026-09-22 | NCT07832370 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Regeneron Pharmaceuticals | 238 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||